- Publication of annual report for financial year 2022
- Annual Shareholders’ Meeting proposed resolutions include re-appointment of Board members and appointment of new statutory auditor
The annual report for the financial year 2022, including a review of figures and performance, is available online at https://www.glpg.com/financial-reports and can also be downloaded as a PDF. Our annual 2022 Form 20-F filing with the
Furthermore, Galapagos has the honor to invite its shareholders, holders of subscription rights, Board members and statutory auditor to its Annual Shareholders’ Meeting (“AGM”) that will be held on Tuesday
The items on the agenda of the AGM include, amongst other items: (i) the re-appointment of Mr.
In order to be admitted to the AGM to be held on
About Galapagos
Galapagos is a fully integrated biotechnology company focused on discovering, developing, and commercializing innovative medicines. We are committed to improving patients’ lives worldwide by targeting diseases with high unmet needs. Our R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Our portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Our first medicine for rheumatoid arthritis and ulcerative colitis is available in
Contacts
Media relations | Investor relations |
+32 479 490 603 | +1 781 296 1143 |
Elisa Chenailler | |
+41 79 853 33 54 | +32 495 58 46 63 |
ir@glpg.com | |
+31 6 22463921 | |
media@glpg.com |
Forward-looking statements
This release may contain forward-looking statements. Such forward-looking statements are not guarantees of future results. These statements speak only as of the date of publication of this release. We expressly disclaim any obligation to update any forward-looking statements in this release, unless specifically required by law or regulation.
Disclaimer
The contents of our website, including the annual report for the financial year 2022, and any other website that may be accessed from our website, shall not be deemed incorporated by reference in any filing under the Securities Act of 1933.
Attachment
- Galapagos publishes 2022 annual report and announces Annual Shareholders’ Meeting
© OMX, source